Brian Dobosh
Impact in
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- Neonatal Respiratory Health Research
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 3
- SARS-CoV-2 detection and testing 2
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Rabindra Tirouvanziam (14 shared papers)Camilla Margaroli (6 shared papers)Amit Gaggar (3 shared papers)J. Edwin Blalock (1 shared paper)Tomasz Szul (1 shared paper)Preston E. Bratcher (1 shared paper)Brett D. Noerager (1 shared paper)Liliana Viera (1 shared paper)
- Journals
- Scientific Reports (2 papers)International Journal of Molecular Sciences (2 papers)Molecular Therapy (1 paper)Nature Chemical Biology (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesSouth AfricaBelgium
In The Last Decade
Brian Dobosh
17 papers receiving 673 citations
Brian Dobosh's Hit Papers
Peers
Comparison fields: 5 of 73
- Immunology 202
- Pulmonary and Respiratory Medicine 184
- Cancer Research 82
- Molecular Biology 395
- Infectious Diseases 87
Countries citing papers authored by Brian Dobosh
This map shows the geographic impact of Brian Dobosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Dobosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Dobosh more than expected).
Fields of papers citing papers by Brian Dobosh
This network shows the impact of papers produced by Brian Dobosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Dobosh. The network helps show where Brian Dobosh may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Dobosh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung Hit paper breakdown → | 2019 | 354 |
| 2 | 2019 | 67 | |
| 3 | 2019 | 59 | |
| 4 | 2018 | 56 | |
| 5 | 2019 | 41 | |
| 6 | 2021 | 30 | |
| 7 | 2022 | 21 | |
| 8 | 2020 | 18 | |
| 9 | 2022 | 11 | |
| 10 | 2024 | 8 | |
| 11 | 2022 | 6 | |
| 12 | 2024 | 4 | |
| 13 | 2021 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2025 | 1 |
About Brian Dobosh
Brian Dobosh is a scholar working on Infectious Diseases, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Epidemiology, having authored 17 papers that have together received 681 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), RNA Interference and Gene Delivery (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Respiratory Support and Mechanisms (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Antimicrobial Peptides and Activities (2 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Immunology (202 citations), Pulmonary and Respiratory Medicine (184 citations), Cancer Research (82 citations), Molecular Biology (395 citations) and Infectious Diseases (87 citations). Brian Dobosh has collaborated with scholars based in United States, South Africa and Belgium. Frequent co-authors include Rabindra Tirouvanziam, Camilla Margaroli, Amit Gaggar, J. Edwin Blalock, Tomasz Szul, Preston E. Bratcher, Brett D. Noerager, Liliana Viera, Carmel M. McNicholas and Gabriel Rezonzew. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences, Molecular Therapy, Nature Chemical Biology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.